European CHMP Opinions and MAA Updates
Executive Summary
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
You may also be interested in...
UK Pips EU To The Post With ‘Project Orbis’ Approval For Tagrisso
The UK drug regulator, the MHRA, has approved its first product under Project Orbis, the US-led international regulatory collaboration scheme it joined four months ago to speed up access to promising cancer medicines.
EMA Says Yes To Eight New Medicines, Holds Fire On Others
The European Medicines Agency today announced the new medicines it believes should be approved for use across the EU.
EU Thumbs Up Signals First-Ever Approval For Leo’s Tralokinumab
Leo’s moderate-to-severe atopic dermatitis drug is set to be approved for the first time worldwide.